PTS Diagnostics-branded controls ensure that our customers have access to a high-quality solution that meets our stringent regulatory guidelines.
WHITESTOWN, Ind. (PRWEB)
March 23, 2020
PTS Diagnostics, a U.S.-based manufacturer of point-of-care medical testing devices announced today that they are launching A1CNow+ Controls for the A1CNow®+ test system.
Initially available in the United States, European Union, and the United Kingdom, A1CNow+ Controls can be stored frozen for up to three years, refrigerated for eight months, or at room temperature for seven days. Intended to ensure accurate A1C results, the solution comes with two levels, each in a dropper style vial and can be successfully run in minutes.
“PTS Diagnostics-branded controls ensure that our customers have access to a high-quality solution that meets our stringent regulatory guidelines,” said Mark Duncan, Director, Global Product Management. “We are excited to provide benefits such as easy-to-use dropper style vials and extended shelf life.”
For additional information about the product, reference the A1CNow+ Controls webpage: ptsdiagnostics.com/a1cnow-plus-system/a1cnow-controls.
Please call customer service at 317-870-5610 (direct) or 877-870-5610 (toll-free US only) with any questions. Connect with your local distribution partner if you are interested in purchasing A1CNow+ Controls or any other product. Find them via ptsdiagnostics.com/distributors.
About PTS Diagnostics
Through its People, Technology and Service, PTS Diagnostics creates health innovation that drives action and results. Since 1992, we have helped medical professionals and patients achieve better health outcomes through our accurate, precise, fast, affordable, and certified point-of-care medical devices. Healthcare professionals have used our CardioChek® products to assess cardiovascular disease risks for millions of patients worldwide through lipid panel screening. And, our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. For more information, visit ptsdiagnostics.com.
Share article on social media or email: